Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Research

Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014

Thelma E. TupasiComments to Author , Anna Marie Celina G. Garfin, Ekaterina V. Kurbatova, Joan M. Mangan, Ruth Orillaza-Chi, Leilani C. Naval, Glenn I. Balane, Ramon Basilio, Alexander Golubkov, Evelyn S. Joson, Woo-jin Lew, Vivian Lofranco, Mariquita Mantala, Stuart Pancho, and Jesus N. Sarol
Author affiliations: Tropical Disease Foundation, Inc., Makati City, the Philippines (T.E. Tupasi, L.C. Naval, G.I. Balane, E.S. Joson, J.N. Sarol Jr.); Department of Health, Manila, the Philippines (A.M.C.G. Garfin, R. Basilio); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E.V. Kurbatova, J.M. Mangan); Philippine Business for Social Progress–Innovations and Multisectoral Partnership to Achieve Control of Tuberculosis Project, Manila (R. Orillaza-Chi); US Agency for International Development (USAID), Washington, DC, USA (A. Golubkov); World Health Organization Philippines, Manila (W.-j. Lew); The Lung Center of the Philippines, Manila (V. Lofranco, S. Pancho); Technical Assistance to the Countries–USAID-funded activity, Manila (M. Mantala)

Main Article

Table 4

Univariate analysis of healthcare setting factors associated with loss to follow-up during treatment for multidrug-resistant TB, the Philippines, 2012–2014*

Characteristic, from data from patient interviews Total Case-patients† Control-patients† Odds ratio (95% CI) p value
Treatment center provided financial assistance or other items to facilitate treatment adherence
Yes 245 69 (76.7) 176 (96.7) 0.11 (0.04–0.29) <0.001
No
 27
 21 (23.3)
 6 (3.3)
 1.00
Types of assistance provided
Food products
Yes 114 27 (29.7) 87 (47.8) 0.46 (0.27–0.79) 0.004
No 159 64 (70.3) 95 (52.2) 1.00
Housing assistance
Yes 15 6 (6.6) 9 (4.9) 1.36 (0.47–3.94) 0.57
No 258 85 (93.4) 173 (95.1) 1.00
Free medications to treat side effects from anti-TB drugs
Yes 196 49 (53.8) 147 (80.8) 0.28 (0.16–0.48) <0.001
No 77 42 (46.2) 35 (19.2) 1.00
Money for transportation
Yes 224 59 (64.8) 165 (90.7) 0.19 (0.1–0.37) <0.001
No
 49
 32 (35.2)
 17 (9.3)
 1.00
Trust in, rapport with, and support from physicians and nursing staff
 273
 81.88 (15.56)‡
 90.73 (7.79)‡
 0.93 (0.91–0.96)§
 <0.001
Information and support from healthcare center staff 272 7.53 (1.68)‡ 8.43 (1.22)‡ 0.64 (0.52–0.78)§ <0.001

*Boldface indicates significance. TB, tuberculosis.
†No (%) unless noted otherwise.
‡Mean (SD).
§Odds ratio is per 1 point increase in cumulative score.

Main Article

Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external